1996
DOI: 10.1016/s0944-7113(96)80042-0
|View full text |Cite
|
Sign up to set email alerts
|

Effect of lecithin on the development of experimental atherosclerosis in rabbits

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
25
0

Year Published

2008
2008
2018
2018

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(26 citation statements)
references
References 24 publications
1
25
0
Order By: Relevance
“…1-5), suggesting that the effects of quercetin on macrophages might be operating in vivo and could explain at least some of the atheroprotective activities of this flavonoid. Our results are in line with previous reports showing atheroprotective effects of oral quercetin in various animal models (Hayek et al, 1997;Auger et al, 2005;Juźwiak et al, 2005;Leckey et al, 2010;Loke et al, 2010;Kleemann et al, 2011) and further extend them by demonstrating a significant level of protection after intraperitoneal chronic administration. Furthermore, we demonstrated reduced inflammatory macrophage and T cell infiltrate in the atheromatous plaque (Fig.…”
supporting
confidence: 93%
See 1 more Smart Citation
“…1-5), suggesting that the effects of quercetin on macrophages might be operating in vivo and could explain at least some of the atheroprotective activities of this flavonoid. Our results are in line with previous reports showing atheroprotective effects of oral quercetin in various animal models (Hayek et al, 1997;Auger et al, 2005;Juźwiak et al, 2005;Leckey et al, 2010;Loke et al, 2010;Kleemann et al, 2011) and further extend them by demonstrating a significant level of protection after intraperitoneal chronic administration. Furthermore, we demonstrated reduced inflammatory macrophage and T cell infiltrate in the atheromatous plaque (Fig.…”
supporting
confidence: 93%
“…Several epidemiological (Hertog et al, 1993(Hertog et al, , 1995 and clinical (Edwards et al, 2007;Egert et al, 2009) studies support the cardioprotective effects of this flavonoid in humans. Moreover, administration of quercetin to rabbits (Juźwiak et al, 2005), hamsters (Auger et al, 2005), and mice (Hayek et al, 1997;Leckey et al, 2010;Loke et al, 2010;Kleemann et al, 2011) inhibits atherosclerosis development, which is the underlying cause of CVD. Cellular and molecular investigations further support quercetin's bioactivity in atherosclerosis and suggest that it acts through antioxidant/cytoprotective and anti-inflammatory mechanisms.…”
Section: Introductionmentioning
confidence: 99%
“…Results of the chemical analysis of T. leontopetaloides extract showed the presence of polyphenols, alkaloid and saponins. Several studies have demonstrated the beneficial effects of polyphenols (Juźwiak et al, 2005;Andreadou et al, 2006) and saponins (Francis et al, 2002;Astuti et al, 2009;Afrose et al, 2010) on the reduction of cholesterol. In this study the rats fed with high fat diet associated with aqueous tubers extract loss the weight and rats receiving high fat diet only gained the weight.…”
Section: Discussionmentioning
confidence: 99%
“…Epidemiological (22) and clinical studies (23) suggest that there is an inverse correlation between flavonoid supplementation and cardiovascular risk, and numerous clinical and animal studies have reported the anti-inflammatory and anti-oxidative functions of quercetin (23)(24)(25)(26)(27)(28)(29). Furthermore, quercetin alleviates AS development in rabbits (30) and mice (31).…”
Section: Introductionmentioning
confidence: 99%